| A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression DR Goldsmith, MH Rapaport, BJ Miller Molecular psychiatry 21 (12), 1696-1709, 2016 | 1701 | 2016 |
| Neural correlates of social cooperation and non-cooperation as a function of psychopathy JK Rilling, AL Glenn, MR Jairam, G Pagnoni, DR Goldsmith, HA Elfenbein, ... Biological psychiatry 61 (11), 1260-1271, 2007 | 557 | 2007 |
| What does plasma CRP tell us about peripheral and central inflammation in depression? JC Felger, E Haroon, TA Patel, DR Goldsmith, EC Wommack, ... Molecular psychiatry 25 (6), 1301-1311, 2020 | 398 | 2020 |
| Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder E Haroon, AW Daguanno, BJ Woolwine, DR Goldsmith, WM Baer, ... Psychoneuroendocrinology 95, 43-49, 2018 | 277 | 2018 |
| The neural correlates of the affective response to unreciprocated cooperation JK Rilling, DR Goldsmith, AL Glenn, MR Jairam, HA Elfenbein, ... Neuropsychologia 46 (5), 1256-1266, 2008 | 246 | 2008 |
| Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions. BJ Miller, DR Goldsmith Neuropsychopharmacology, 2016 | 186 | 2016 |
| Social cognitive neural networks during in-group and out-group interactions JK Rilling, JE Dagenais, DR Goldsmith, AL Glenn, G Pagnoni Neuroimage 41 (4), 1447-1461, 2008 | 151 | 2008 |
| Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression E Haroon, JR Welle, BJ Woolwine, DR Goldsmith, W Baer, T Patel, ... Neuropsychopharmacology 45 (6), 998-1007, 2020 | 149 | 2020 |
| Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder DR Goldsmith, E Haroon, BJ Woolwine, MY Jung, EC Wommack, ... Brain, behavior, and immunity 56, 281-288, 2016 | 141 | 2016 |
| TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia DR Goldsmith, E Haroon, AH Miller, GP Strauss, PF Buckley, BJ Miller Schizophrenia research 199, 281-284, 2018 | 121 | 2018 |
| Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology DR Goldsmith, M Bekhbat, ND Mehta, JC Felger Biological psychiatry 93 (5), 405-418, 2023 | 100 | 2023 |
| Inflammation and negative symptoms of schizophrenia: implications for reward processing and motivational deficits DR Goldsmith, MH Rapaport Frontiers in psychiatry 11, 46, 2020 | 92 | 2020 |
| Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis DR Goldsmith, E Haroon, AH Miller, J Addington, C Bearden, ... Brain, behavior, and immunity 76, 268-274, 2019 | 75 | 2019 |
| Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology BJ Miller, DR Goldsmith Biomarkers in Neuropsychiatry 1, 100006, 2019 | 70 | 2019 |
| Aiding and abetting anhedonia: impact of inflammation on the brain and pharmacological implications MJ Lucido, M Bekhbat, DR Goldsmith, MT Treadway, E Haroon, JC Felger, ... Pharmacological Reviews 73 (3), 1084-1117, 2021 | 66 | 2021 |
| Evaluating the hypothesis that schizophrenia is an inflammatory disorder BJ Miller, DR Goldsmith Focus 18 (4), 391-401, 2020 | 59 | 2020 |
| Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia M Bekhbat, MT Treadway, DR Goldsmith, BJ Woolwine, E Haroon, ... Brain, behavior, and immunity 88, 161-165, 2020 | 56 | 2020 |
| Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: a review of the literature and recommendations for the COVID-19 pandemic A Zimmer, A Youngblood, A Adnane, BJ Miller, DR Goldsmith Brain, behavior, and immunity 91, 756-770, 2021 | 53 | 2021 |
| Suicide prevention in schizophrenia: Do long-acting injectable antipsychotics (LAIs) have a role? M Pompili, L Orsolini, D A. Lamis, D R. Goldsmith, A Nardella, G Falcone, ... CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders) 16 …, 2017 | 38 | 2017 |
| An update on promising biomarkers in schizophrenia DR Goldsmith, CL Crooks, EF Walker, RO Cotes Focus 16 (2), 153-163, 2018 | 31 | 2018 |